India Over the Counter Drugs (OTC) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Indian Over-the-counter (OTC) Drugs Market is Segmented by Product and Distribution Channel (Retail Pharmacies, Online Pharmacy, and Other Distribution Channels).

Market Snapshot

Study Period:

2018 - 2026

Base Year:



9.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Indian OTC market is expected to attain a good CAGR over the forecast period, 2020-2025.

The key factors propelling the growth of the Indian over-the-counter drugs market are the shift in consumer attitude toward self-medication, product innovations, and inclination of pharmaceutical companies toward OTC drugs from prescription (RX) drugs.

India is one of the emerging markets for OTC drugs and offers significant growth potential for the industry. The market is growing in India due to the increasing healthcare expenditure, unhealthy dietary habits, expanding population, and growing healthcare awareness.

The increasing disposable income of people, along with a shift in the consumer attitude toward self-medication and increasing geriatric population are the two major factors driving the overall market in the region. Thus, increasing awareness about the cost-effectiveness of self-medication and OTC medicines is a crucial factor that is fueling the market growth.

There is also the rapidly growing population, coupled with the fact that the middle class in this country is expanding on a large scale, which may add critical mass to the population available to access OTC medication. Thus, the increasing investments of market giants in the emerging market are expected to drive the growth of the overall market.

Scope of the Report

As per the scope of the report, over-the-counter drugs are referred to the non-prescription drugs. These medicines can be bought by individuals without a doctor’s prescription and are safe for consumption without the doctor’s consent. There are a wide number of therapeutic applications for OTC drugs ranging from weight control drugs to analgesic drugs.

By Product
Cough, Cold, and Flu Products
Dermatology Products
Gastrointestinal Products
Vitamins, Minerals, and Supplements (VMS)
Other Products
By Distribution Channel
Hospital Pharmacies
Retail Pharmacy
Other Distribution Channels

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Analgesics Segment is Expected to Register the Largest Growth over the Forecast Period

Analgesics accounted for a significant value share of the over-the-counter (OTC) drugs market. OTC analgesics have several applications in the treatment of fever, headache, musculoskeletal injuries and disorders, arthritis, and menstrual cramps that have spurred the overall demand in the market. Other factors, such as obesity, stress, and lifestyle disorders lead to chronic pain and different kinds of aches. The population is widespread in the developed markets, as well as in high economic growth countries, such as India and China. Therefore, in these countries, the population contributes to the increasing demand for and growth of analgesics in the market.


To understand key trends, Download Sample Report

Competitive Landscape

The industry players are focusing on new product developments and acquisition strategies to gain market shares. The developing countries have also opened new growth avenues for pharmaceutical companies. Thus, the market has different challenges and requires innovative products facilitating new innovative OTC drugs.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Shift toward Self Medication by Consumers

      2. 4.2.2 Product Innovations

      3. 4.2.3 Inclination of Pharmaceutical Companies toward OTC Drugs from RX Drugs

    3. 4.3 Market Restraints

      1. 4.3.1 Price Cuts for Various Ingredients and Restrictions for Advertising

      2. 4.3.2 Lack of Specific Regulations for OTC Drugs

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Cough, Cold, and Flu Products

      2. 5.1.2 Analgesics

      3. 5.1.3 Dermatology Products

      4. 5.1.4 Gastrointestinal Products

      5. 5.1.5 Vitamins, Minerals, and Supplements (VMS)

      6. 5.1.6 Other Products

    2. 5.2 By Distribution Channel

      1. 5.2.1 Hospital Pharmacies

      2. 5.2.2 Retail Pharmacy

      3. 5.2.3 Other Distribution Channels


    1. 6.1 Company Profiles

      1. 6.1.1 GlaxoSmithKline PLC

      2. 6.1.2 Emami Limited

      3. 6.1.3 Abbott Laboratories

      4. 6.1.4 Dabur India Limited

      5. 6.1.5 Procter & Gamble

      6. 6.1.6 Reckitt Benckiser

      7. 6.1.7 Sun Pharmaceuticals Limited

      8. 6.1.8 Cipla Inc.

      9. 6.1.9 Takeda Pharmaceutical Company

      10. 6.1.10 Johnson & Johnson

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The India Over the Counter Drugs (OTC) Market market is studied from 2018 - 2026.

The India Over the Counter Drugs (OTC) Market is growing at a CAGR of 9.2% over the next 5 years.

  • Emami Limited
  • Dabur India Limited
  • Procter & Gamble
  • Abbott Laboratories
  • GlaxoSmithKline PLC

Are the major companies operating in India Over the Counter Drugs (OTC) Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!